The US market is seeing a shift in market dynamics and several factors lead to drug product pricing and there will be further pricing pressure over the next few years, said GSK Global Chief Executive Andrew Witty.
first published: Nov 8, 2016 03:00 pm
A collection of the most-viewed Moneycontrol videos.
Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
Will D-Street See A Sweet Start To November? Autos In Focus After Record Sales| Opening Bell Live
The Sikkim Girl Trying to Make it Big in Mumbai | Tenant
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
